Cardiac Dimensions has raised $39 million to build strong clinical evidence for its Carillon Mitral Contour System, so the device can more effectively compete in the functional mitral regurgitation treatment market.
Cardiac Dimensions has raised $39 million to build strong clinical evidence for its Carillon Mitral Contour System, so the device can more effectively compete in the functional mitral regurgitation treatment market.